Bocunebart shows significant reduction in monthly migraine days in patients with previous treatment failures
Category: News
New group aims to address structural barriers holding back Europe’s biotech scale‑up
FDA designation aims to speed development of new diagnostic tool
ProLectin‑M achieves 100% viral elimination by day seven in placebo‑controlled study
Biocodex secures rights to Batten-1 and TX01 in agreement worth up to €173 million
Regulator recommends durvalumab as first perioperative IO option for muscle‑invasive disease
Re:Cognition Health and Cera collaborate to expand access to Alzheimer’s and neurodegenerative clinical trials
Oral candidate shows favourable safety profile and signs of clinical activity in NPDR
Recognising the achievements of this year’s standout healthcare collaborations
The company will initially develop a vaccine to tackle colorectal and pancreatic cancers